Traws Pharma, Inc. Increase (Decrease) in Deferred Revenue
Traws Pharma, Inc. (TRAW) reported Increase (Decrease) in Deferred Revenue of -$454.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-03-16
- Traws Pharma, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$114.00K.
- Traws Pharma, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$113.00K.
- Traws Pharma, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$114.00K.
- Traws Pharma, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-03-31 was -$113.00K.
- Traws Pharma, Inc. increase (decrease) in deferred revenue for fiscal 2017 was -$454.00K.
- Traws Pharma, Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$455.00K.
- Traws Pharma, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$8.46M.
- Traws Pharma, Inc. increase (decrease) in deferred revenue for fiscal 2014 was -$787.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2017-12-31 | -$114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$227.00K derived: sum of 2 quarters · filed 2018-03-16 | -$341.00K derived: sum of 3 quarters · filed 2018-03-16 | -$454.00K 10-K · filed 2018-03-16 |
| 2017-09-30 | -$113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$227.00K derived: sum of 2 quarters · filed 2017-11-09 | -$340.00K 10-Q · filed 2017-11-09 | -$454.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-06-30 | -$114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$227.00K 10-Q · filed 2017-08-14 | -$341.00K derived: sum of 3 quarters · filed 2018-03-16 | -$455.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2017-03-31 | -$113.00K 10-Q · filed 2017-05-15 | -$227.00K derived: sum of 2 quarters · filed 2018-03-16 | -$341.00K derived: sum of 3 quarters · filed 2018-03-16 | -$454.00K derived: sum of 4 quarters · filed 2018-03-16 |
| 2016-12-31 | -$114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$228.00K derived: sum of 2 quarters · filed 2018-03-16 | -$341.00K derived: sum of 3 quarters · filed 2018-03-16 | -$455.00K 10-K · filed 2018-03-16 |
| 2016-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$227.00K derived: sum of 2 quarters · filed 2017-11-09 | -$341.00K 10-Q · filed 2017-11-09 | -$8.46M derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$227.00K 10-Q · filed 2017-08-14 | -$8.34M derived: sum of 3 quarters · filed 2017-08-14 | -$8.45M derived: sum of 4 quarters · filed 2017-08-14 |
| 2016-03-31 | -$114.00K 10-Q · filed 2017-05-15 | -$8.23M derived: sum of 2 quarters · filed 2017-05-15 | -$8.34M derived: sum of 3 quarters · filed 2017-05-15 | -$8.46M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | -$8.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$8.23M derived: sum of 2 quarters · filed 2017-03-29 | -$8.34M derived: sum of 3 quarters · filed 2017-03-29 | -$8.46M 10-K · filed 2017-03-29 |
| 2015-09-30 | -$113.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$227.00K derived: sum of 2 quarters · filed 2016-11-14 | -$341.00K 10-Q · filed 2016-11-14 | -$454.00K derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | -$114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$228.00K 10-Q · filed 2016-08-15 | -$341.00K derived: sum of 3 quarters · filed 2016-08-15 | -$455.00K derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | -$114.00K 10-Q · filed 2016-05-11 | -$227.00K derived: sum of 2 quarters · filed 2016-05-11 | -$341.00K derived: sum of 3 quarters · filed 2016-05-11 | -$454.00K derived: sum of 4 quarters · filed 2016-05-11 |
| 2014-12-31 | -$113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | -$227.00K derived: sum of 2 quarters · filed 2016-03-28 | -$340.00K derived: sum of 3 quarters · filed 2016-03-28 | -$787.00K 10-K · filed 2016-03-28 |
| 2014-09-30 | -$114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$227.00K derived: sum of 2 quarters · filed 2015-11-12 | -$674.00K 10-Q · filed 2015-11-12 | -$2.53M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | -$113.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$560.00K 10-Q · filed 2015-08-13 | -$2.42M derived: sum of 3 quarters · filed 2015-08-13 | -$3.51M derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | -$447.00K 10-Q · filed 2015-05-15 | -$2.30M derived: sum of 2 quarters · filed 2015-05-15 | -$3.40M derived: sum of 3 quarters · filed 2015-05-15 | -$3.99M derived: sum of 4 quarters · filed 2015-05-15 |
| 2013-12-31 | -$1.86M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | -$2.95M derived: sum of 2 quarters · filed 2015-03-30 | -$3.54M derived: sum of 3 quarters · filed 2015-03-30 | -$4.63M 10-K · filed 2015-03-30 |
| 2013-09-30 | -$1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$1.68M derived: sum of 2 quarters · filed 2014-11-14 | -$2.77M 10-Q · filed 2014-11-14 | -$5.74M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-06-30 | -$591.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.68M 10-Q · filed 2014-08-14 | -$4.65M derived: sum of 3 quarters · filed 2015-03-30 | $3.10M derived: sum of 4 quarters · filed 2015-03-30 |
| 2013-03-31 | -$1.09M 10-Q · filed 2014-05-15 | -$4.06M derived: sum of 2 quarters · filed 2015-03-30 | $3.69M derived: sum of 3 quarters · filed 2015-03-30 | |
| 2012-12-31 | -$2.97M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $4.78M derived: sum of 2 quarters · filed 2015-03-30 | $8.15M 10-K · filed 2015-03-30 | |
| 2012-09-30 | $7.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $11.12M 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | $3.37M 10-Q · filed 2013-09-06 | |||
| 2011-12-31 | $7.67M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |